Skip to content

Christopher Peetz, Chief Executive Officer at Mirum Pharmaceuticals, sold MIRM on Jul 6, 2026

Data as of Oct 16

▼ SELL$213K1,710 shares at $124.79Christopher Peetz Chief Executive OfficerMIRM Mirum Pharmaceuticals, Inc.
Watch MIRM
Traded
Jul 6, 2026
Disclosed
Jul 8, 2026
Filed
2 days after the trade

Form 4s are due within two business days.

Official filing (SEC Form 4) ↗

The price around the disclosure

Christopher Peetz, Chief Executive Officer at Mirum Pharmaceuticals, sold MIRM on Jul 6, 2026TRADEDDISCLOSED
MIRMSimilar stocks (XLV — its sector index fund), rebased to MIRM's price on the disclosure day
MIRM since disclosure
−37.7%
after the sale
Similar stocks (XLV) since disclosure
+8.9%
XLV — its sector index fund

Change in closing price from Jul 8, 2026 (the first trading day on or after disclosure) to Oct 16, 2026. Dividends excluded. Not a return anyone earned.

Our take

None of our tested rules fired on this trade.

Other trades in the same filing

  1. ▼ SELLChristopher Peetz Chief Executive OfficerMIRM Mirum Pharmaceuticals, Inc.$512Kdisclosed Jul 8 · filed 2 days after the trade
  2. ▼ SELLChristopher Peetz Chief Executive OfficerMIRM Mirum Pharmaceuticals, Inc.$1.5Mdisclosed Jul 8 · filed 2 days after the trade
  3. ▼ SELLChristopher Peetz Chief Executive OfficerMIRM Mirum Pharmaceuticals, Inc.$244Kdisclosed Jul 8 · filed 2 days after the trade

See every trade on MIRM →